Covered recipient · General Payments record
LANCE SCOTT
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$4,380.43
- Reported across 112 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,089.68 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $548.95 | 12 |
| Sandoz Inc. | $156.07 | 7 |
| Apellis Pharmaceuticals, Inc. | $154.47 | 2 |
| Genentech USA, Inc. | $83.89 | 3 |
| Alimera Sciences, Inc. | $67.66 | 1 |
| Coherus Biosciences Inc. | $33.67 | 1 |
| ANI Pharmaceuticals, Inc. | $24.24 | 1 |
| ABBVIE INC. | $20.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.73 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106048464 | CMS |
| Alimera Sciences, Inc. | $67.66 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092830128 | CMS |
| ANI Pharmaceuticals, Inc. | $24.24 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091163116 | CMS |
| Apellis Pharmaceuticals, Inc. | $31.92 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154024781 | CMS |
| Apellis Pharmaceuticals, Inc. | $122.55 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154024783 | CMS |
| Biogen, Inc. | $17.57 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104814111 | CMS |
| Biogen, Inc. | $11.43 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104867740 | CMS |
| Biogen, Inc. | $107.67 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104847332 | CMS |
| Biogen, Inc. | $19.52 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104822974 | CMS |
| Biogen, Inc. | $20.22 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104848502 | CMS |
| Biogen, Inc. | $98.86 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104824168 | CMS |
| Biogen, Inc. | $20.71 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104827542 | CMS |
| Biogen, Inc. | $15.58 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104832076 | CMS |
| Biogen, Inc. | $15.59 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104836908 | CMS |
| Biogen, Inc. | $148.63 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104853026 | CMS |
| Biogen, Inc. | $16.16 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104832078 | CMS |
| Biogen, Inc. | $57.01 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104873578 | CMS |
| Coherus Biosciences Inc. | $33.67 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147278172 | CMS |
| Genentech USA, Inc. | $35.43 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133050925 | CMS |
| Genentech USA, Inc. | $23.45 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133050930 | CMS |
| Genentech USA, Inc. | $25.01 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133050935 | CMS |
| Sandoz Inc. | $38.03 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089367530 | CMS |
| Sandoz Inc. | $33.28 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089367592 | CMS |
| Sandoz Inc. | $26.82 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089367580 | CMS |
| Sandoz Inc. | $23.32 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089367564 | CMS |
| Sandoz Inc. | $3.30 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089367560 | CMS |
| Sandoz Inc. | $27.34 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089367616 | CMS |
| Sandoz Inc. | $3.98 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089367618 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.